Vaccine supply chains must remain water-tight amid the oncoming sea of demand. With the flu season upon us and over 12.3 million confirmed cases of coronavirus, data solutions answer concerns around how to safely prepare for what’s ahead for our industry. SkyCell is now recognized as a critical supplier by the Swiss government and the EU Commission, due to our vital role in sustaining global pharma supply chains and maintaining an audited performance of less than 0.1% temperature excursions. Based on our experience, here’s why data insights are essential to guaranteeing the life-saving distribution of the future coronavirus vaccine.